As the global economy mends, the 2021 growth of Mesalamine (Lialda) will have significant change from previous year. According to our (LP Information) latest study, the global Mesalamine (Lialda) market size is USD million in 2022 from USD 153.1 million in 2021, with a change of % between 2021 and 2022. The global Mesalamine (Lialda) market size will reach USD 191.6 million in 2028, growing at a CAGR of 3.3% over the analysis period.
The United States Mesalamine (Lialda) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Mesalamine (Lialda) market, reaching US$ million by the year 2028. As for the Europe Mesalamine (Lialda) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Mesalamine (Lialda) players cover Dr.Falk Pharma, Ferring, Ethypharm Pharmaceutical, and Shanghai Pharmaceutical, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Mesalamine (Lialda) market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
- Enemas
- Tablets
- Suppositories
- Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
- Colitis
- Crohn's Disease
- Proctitis
- Diarrheal Irritable Bowel Syndrome
- Diverticulitis
- Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
- Dr.Falk Pharma
- Ferring
- Ethypharm Pharmaceutical
- Shanghai Pharmaceutical
- Tillotts Pharma
- Holy Stone Healthcare
- Giuliani
- Zeria
- Lupin
- Heilongjiang Tianhong Pharmaceutical
- HENGCHENG PHARMACEUTICAL
- KWAI FA Pharmaceutical Group
Global Mesalamine (Lialda) Market Growth (Status and Outlook) 2022-2028
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Mesalamine (Lialda) Market Size 2017-2028
2.1.2 Mesalamine (Lialda) Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Mesalamine (Lialda) Segment by Type
2.2.1 Enemas
2.2.2 Tablets
2.2.3 Suppositories
2.2.4 Other
2.3 Mesalamine (Lialda) Market Size by Type
2.3.1 Mesalamine (Lialda) Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Mesalamine (Lialda) Market Size Market Share by Type (2017-2022)
2.4 Mesalamine (Lialda) Segment by Application
2.4.1 Colitis
2.4.2 Crohn's Disease
2.4.3 Proctitis
2.4.4 Diarrheal Irritable Bowel Syndrome
2.4.5 Diverticulitis
2.4.6 Other
2.5 Mesalamine (Lialda) Market Size by Application
2.5.1 Mesalamine (Lialda) Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Mesalamine (Lialda) Market Size Market Share by Application (2017-2022)
3 Mesalamine (Lialda) Market Size by Player
3.1 Mesalamine (Lialda) Market Size Market Share by Players
3.1.1 Global Mesalamine (Lialda) Revenue by Players (2020-2022)
3.1.2 Global Mesalamine (Lialda) Revenue Market Share by Players (2020-2022)
3.2 Global Mesalamine (Lialda) Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Mesalamine (Lialda) by Regions
4.1 Mesalamine (Lialda) Market Size by Regions (2017-2022)
4.2 Americas Mesalamine (Lialda) Market Size Growth (2017-2022)
4.3 APAC Mesalamine (Lialda) Market Size Growth (2017-2022)
4.4 Europe Mesalamine (Lialda) Market Size Growth (2017-2022)
4.5 Middle East & Africa Mesalamine (Lialda) Market Size Growth (2017-2022)
5 Americas
5.1 Americas Mesalamine (Lialda) Market Size by Country (2017-2022)
5.2 Americas Mesalamine (Lialda) Market Size by Type (2017-2022)
5.3 Americas Mesalamine (Lialda) Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Mesalamine (Lialda) Market Size by Region (2017-2022)
6.2 APAC Mesalamine (Lialda) Market Size by Type (2017-2022)
6.3 APAC Mesalamine (Lialda) Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Mesalamine (Lialda) by Country (2017-2022)
7.2 Europe Mesalamine (Lialda) Market Size by Type (2017-2022)
7.3 Europe Mesalamine (Lialda) Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Mesalamine (Lialda) by Region (2017-2022)
8.2 Middle East & Africa Mesalamine (Lialda) Market Size by Type (2017-2022)
8.3 Middle East & Africa Mesalamine (Lialda) Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Mesalamine (Lialda) Market Forecast
10.1 Global Mesalamine (Lialda) Forecast by Regions (2023-2028)
10.1.1 Global Mesalamine (Lialda) Forecast by Regions (2023-2028)
10.1.2 Americas Mesalamine (Lialda) Forecast
10.1.3 APAC Mesalamine (Lialda) Forecast
10.1.4 Europe Mesalamine (Lialda) Forecast
10.1.5 Middle East & Africa Mesalamine (Lialda) Forecast
10.2 Americas Mesalamine (Lialda) Forecast by Country (2023-2028)
10.2.1 United States Mesalamine (Lialda) Market Forecast
10.2.2 Canada Mesalamine (Lialda) Market Forecast
10.2.3 Mexico Mesalamine (Lialda) Market Forecast
10.2.4 Brazil Mesalamine (Lialda) Market Forecast
10.3 APAC Mesalamine (Lialda) Forecast by Region (2023-2028)
10.3.1 China Mesalamine (Lialda) Market Forecast
10.3.2 Japan Mesalamine (Lialda) Market Forecast
10.3.3 Korea Mesalamine (Lialda) Market Forecast
10.3.4 Southeast Asia Mesalamine (Lialda) Market Forecast
10.3.5 India Mesalamine (Lialda) Market Forecast
10.3.6 Australia Mesalamine (Lialda) Market Forecast
10.4 Europe Mesalamine (Lialda) Forecast by Country (2023-2028)
10.4.1 Germany Mesalamine (Lialda) Market Forecast
10.4.2 France Mesalamine (Lialda) Market Forecast
10.4.3 UK Mesalamine (Lialda) Market Forecast
10.4.4 Italy Mesalamine (Lialda) Market Forecast
10.4.5 Russia Mesalamine (Lialda) Market Forecast
10.5 Middle East & Africa Mesalamine (Lialda) Forecast by Region (2023-2028)
10.5.1 Egypt Mesalamine (Lialda) Market Forecast
10.5.2 South Africa Mesalamine (Lialda) Market Forecast
10.5.3 Israel Mesalamine (Lialda) Market Forecast
10.5.4 Turkey Mesalamine (Lialda) Market Forecast
10.5.5 GCC Countries Mesalamine (Lialda) Market Forecast
10.6 Global Mesalamine (Lialda) Forecast by Type (2023-2028)
10.7 Global Mesalamine (Lialda) Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Dr.Falk Pharma
11.1.1 Dr.Falk Pharma Company Information
11.1.2 Dr.Falk Pharma Mesalamine (Lialda) Product Offered
11.1.3 Dr.Falk Pharma Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Dr.Falk Pharma Main Business Overview
11.1.5 Dr.Falk Pharma Latest Developments
11.2 Ferring
11.2.1 Ferring Company Information
11.2.2 Ferring Mesalamine (Lialda) Product Offered
11.2.3 Ferring Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Ferring Main Business Overview
11.2.5 Ferring Latest Developments
11.3 Ethypharm Pharmaceutical
11.3.1 Ethypharm Pharmaceutical Company Information
11.3.2 Ethypharm Pharmaceutical Mesalamine (Lialda) Product Offered
11.3.3 Ethypharm Pharmaceutical Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Ethypharm Pharmaceutical Main Business Overview
11.3.5 Ethypharm Pharmaceutical Latest Developments
11.4 Shanghai Pharmaceutical
11.4.1 Shanghai Pharmaceutical Company Information
11.4.2 Shanghai Pharmaceutical Mesalamine (Lialda) Product Offered
11.4.3 Shanghai Pharmaceutical Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Shanghai Pharmaceutical Main Business Overview
11.4.5 Shanghai Pharmaceutical Latest Developments
11.5 Tillotts Pharma
11.5.1 Tillotts Pharma Company Information
11.5.2 Tillotts Pharma Mesalamine (Lialda) Product Offered
11.5.3 Tillotts Pharma Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Tillotts Pharma Main Business Overview
11.5.5 Tillotts Pharma Latest Developments
11.6 Holy Stone Healthcare
11.6.1 Holy Stone Healthcare Company Information
11.6.2 Holy Stone Healthcare Mesalamine (Lialda) Product Offered
11.6.3 Holy Stone Healthcare Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Holy Stone Healthcare Main Business Overview
11.6.5 Holy Stone Healthcare Latest Developments
11.7 Giuliani
11.7.1 Giuliani Company Information
11.7.2 Giuliani Mesalamine (Lialda) Product Offered
11.7.3 Giuliani Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Giuliani Main Business Overview
11.7.5 Giuliani Latest Developments
11.8 Zeria
11.8.1 Zeria Company Information
11.8.2 Zeria Mesalamine (Lialda) Product Offered
11.8.3 Zeria Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Zeria Main Business Overview
11.8.5 Zeria Latest Developments
11.9 Lupin
11.9.1 Lupin Company Information
11.9.2 Lupin Mesalamine (Lialda) Product Offered
11.9.3 Lupin Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Lupin Main Business Overview
11.9.5 Lupin Latest Developments
11.10 Heilongjiang Tianhong Pharmaceutical
11.10.1 Heilongjiang Tianhong Pharmaceutical Company Information
11.10.2 Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Product Offered
11.10.3 Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Heilongjiang Tianhong Pharmaceutical Main Business Overview
11.10.5 Heilongjiang Tianhong Pharmaceutical Latest Developments
11.11 HENGCHENG PHARMACEUTICAL
11.11.1 HENGCHENG PHARMACEUTICAL Company Information
11.11.2 HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Product Offered
11.11.3 HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 HENGCHENG PHARMACEUTICAL Main Business Overview
11.11.5 HENGCHENG PHARMACEUTICAL Latest Developments
11.12 KWAI FA Pharmaceutical Group
11.12.1 KWAI FA Pharmaceutical Group Company Information
11.12.2 KWAI FA Pharmaceutical Group Mesalamine (Lialda) Product Offered
11.12.3 KWAI FA Pharmaceutical Group Mesalamine (Lialda) Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 KWAI FA Pharmaceutical Group Main Business Overview
11.12.5 KWAI FA Pharmaceutical Group Latest Developments
12 Research Findings and Conclusion
List of Tables
Table 1. Mesalamine (Lialda) Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Enemas
Table 3. Major Players of Tablets
Table 4. Major Players of Suppositories
Table 5. Major Players of Other
Table 6. Mesalamine (Lialda) Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Mesalamine (Lialda) Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Mesalamine (Lialda) Market Size Market Share by Type (2017-2022)
Table 9. Mesalamine (Lialda) Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Mesalamine (Lialda) Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Mesalamine (Lialda) Market Size Market Share by Application (2017-2022)
Table 12. Global Mesalamine (Lialda) Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Mesalamine (Lialda) Revenue Market Share by Player (2020-2022)
Table 14. Mesalamine (Lialda) Key Players Head office and Products Offered
Table 15. Mesalamine (Lialda) Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Mesalamine (Lialda) Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Mesalamine (Lialda) Market Size Market Share by Regions (2017-2022)
Table 20. Americas Mesalamine (Lialda) Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Mesalamine (Lialda) Market Size Market Share by Country (2017-2022)
Table 22. Americas Mesalamine (Lialda) Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Mesalamine (Lialda) Market Size Market Share by Type (2017-2022)
Table 24. Americas Mesalamine (Lialda) Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Mesalamine (Lialda) Market Size Market Share by Application (2017-2022)
Table 26. APAC Mesalamine (Lialda) Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Mesalamine (Lialda) Market Size Market Share by Region (2017-2022)
Table 28. APAC Mesalamine (Lialda) Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Mesalamine (Lialda) Market Size Market Share by Type (2017-2022)
Table 30. APAC Mesalamine (Lialda) Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Mesalamine (Lialda) Market Size Market Share by Application (2017-2022)
Table 32. Europe Mesalamine (Lialda) Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Mesalamine (Lialda) Market Size Market Share by Country (2017-2022)
Table 34. Europe Mesalamine (Lialda) Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Mesalamine (Lialda) Market Size Market Share by Type (2017-2022)
Table 36. Europe Mesalamine (Lialda) Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Mesalamine (Lialda) Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Mesalamine (Lialda) Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Mesalamine (Lialda) Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Mesalamine (Lialda) Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Mesalamine (Lialda) Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Mesalamine (Lialda) Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Mesalamine (Lialda) Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Mesalamine (Lialda)
Table 45. Key Market Challenges & Risks of Mesalamine (Lialda)
Table 46. Key Industry Trends of Mesalamine (Lialda)
Table 47. Global Mesalamine (Lialda) Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Mesalamine (Lialda) Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Mesalamine (Lialda) Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Mesalamine (Lialda) Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Mesalamine (Lialda) Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Mesalamine (Lialda) Market Size Market Share Forecast by Application (2023-2028)
Table 53. Dr.Falk Pharma Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 54. Dr.Falk Pharma Mesalamine (Lialda) Product Offered
Table 55. Dr.Falk Pharma Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. Dr.Falk Pharma Main Business
Table 57. Dr.Falk Pharma Latest Developments
Table 58. Ferring Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 59. Ferring Mesalamine (Lialda) Product Offered
Table 60. Ferring Main Business
Table 61. Ferring Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. Ferring Latest Developments
Table 63. Ethypharm Pharmaceutical Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 64. Ethypharm Pharmaceutical Mesalamine (Lialda) Product Offered
Table 65. Ethypharm Pharmaceutical Main Business
Table 66. Ethypharm Pharmaceutical Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Ethypharm Pharmaceutical Latest Developments
Table 68. Shanghai Pharmaceutical Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 69. Shanghai Pharmaceutical Mesalamine (Lialda) Product Offered
Table 70. Shanghai Pharmaceutical Main Business
Table 71. Shanghai Pharmaceutical Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Shanghai Pharmaceutical Latest Developments
Table 73. Tillotts Pharma Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 74. Tillotts Pharma Mesalamine (Lialda) Product Offered
Table 75. Tillotts Pharma Main Business
Table 76. Tillotts Pharma Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Tillotts Pharma Latest Developments
Table 78. Holy Stone Healthcare Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 79. Holy Stone Healthcare Mesalamine (Lialda) Product Offered
Table 80. Holy Stone Healthcare Main Business
Table 81. Holy Stone Healthcare Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. Holy Stone Healthcare Latest Developments
Table 83. Giuliani Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 84. Giuliani Mesalamine (Lialda) Product Offered
Table 85. Giuliani Main Business
Table 86. Giuliani Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Giuliani Latest Developments
Table 88. Zeria Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 89. Zeria Mesalamine (Lialda) Product Offered
Table 90. Zeria Main Business
Table 91. Zeria Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Zeria Latest Developments
Table 93. Lupin Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 94. Lupin Mesalamine (Lialda) Product Offered
Table 95. Lupin Main Business
Table 96. Lupin Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Lupin Latest Developments
Table 98. Heilongjiang Tianhong Pharmaceutical Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 99. Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Product Offered
Table 100. Heilongjiang Tianhong Pharmaceutical Main Business
Table 101. Heilongjiang Tianhong Pharmaceutical Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Heilongjiang Tianhong Pharmaceutical Latest Developments
Table 103. HENGCHENG PHARMACEUTICAL Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 104. HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Product Offered
Table 105. HENGCHENG PHARMACEUTICAL Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. HENGCHENG PHARMACEUTICAL Main Business
Table 107. HENGCHENG PHARMACEUTICAL Latest Developments
Table 108. KWAI FA Pharmaceutical Group Details, Company Type, Mesalamine (Lialda) Area Served and Its Competitors
Table 109. KWAI FA Pharmaceutical Group Mesalamine (Lialda) Product Offered
Table 110. KWAI FA Pharmaceutical Group Main Business
Table 111. KWAI FA Pharmaceutical Group Mesalamine (Lialda) Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. KWAI FA Pharmaceutical Group Latest Developments
List of Figures
Figure 1. Mesalamine (Lialda) Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Mesalamine (Lialda) Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Mesalamine (Lialda) Market Size Market Share by Type in 2021
Figure 7. Mesalamine (Lialda) in Colitis
Figure 8. Global Mesalamine (Lialda) Market: Colitis (2017-2022) & ($ Millions)
Figure 9. Mesalamine (Lialda) in Crohn's Disease
Figure 10. Global Mesalamine (Lialda) Market: Crohn's Disease (2017-2022) & ($ Millions)
Figure 11. Mesalamine (Lialda) in Proctitis
Figure 12. Global Mesalamine (Lialda) Market: Proctitis (2017-2022) & ($ Millions)
Figure 13. Mesalamine (Lialda) in Diarrheal Irritable Bowel Syndrome
Figure 14. Global Mesalamine (Lialda) Market: Diarrheal Irritable Bowel Syndrome (2017-2022) & ($ Millions)
Figure 15. Mesalamine (Lialda) in Diverticulitis
Figure 16. Global Mesalamine (Lialda) Market: Diverticulitis (2017-2022) & ($ Millions)
Figure 17. Mesalamine (Lialda) in Other
Figure 18. Global Mesalamine (Lialda) Market: Other (2017-2022) & ($ Millions)
Figure 19. Global Mesalamine (Lialda) Market Size Market Share by Application in 2021
Figure 20. Global Mesalamine (Lialda) Revenue Market Share by Player in 2021
Figure 21. Global Mesalamine (Lialda) Market Size Market Share by Regions (2017-2022)
Figure 22. Americas Mesalamine (Lialda) Market Size 2017-2022 ($ Millions)
Figure 23. APAC Mesalamine (Lialda) Market Size 2017-2022 ($ Millions)
Figure 24. Europe Mesalamine (Lialda) Market Size 2017-2022 ($ Millions)
Figure 25. Middle East & Africa Mesalamine (Lialda) Market Size 2017-2022 ($ Millions)
Figure 26. Americas Mesalamine (Lialda) Value Market Share by Country in 2021
Figure 27. Americas Mesalamine (Lialda) Consumption Market Share by Type in 2021
Figure 28. Americas Mesalamine (Lialda) Market Size Market Share by Application in 2021
Figure 29. United States Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 30. Canada Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 31. Mexico Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 32. Brazil Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 33. APAC Mesalamine (Lialda) Market Size Market Share by Region in 2021
Figure 34. APAC Mesalamine (Lialda) Market Size Market Share by Application in 2021
Figure 35. China Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 36. Japan Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 37. Korea Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 38. Southeast Asia Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 39. India Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 40. Australia Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 41. Europe Mesalamine (Lialda) Market Size Market Share by Country in 2021
Figure 42. Europe Mesalamine (Lialda) Market Size Market Share by Type in 2021
Figure 43. Europe Mesalamine (Lialda) Market Size Market Share by Application in 2021
Figure 44. Germany Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 45. France Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 46. UK Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 47. Italy Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 48. Russia Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 49. Middle East & Africa Mesalamine (Lialda) Market Size Market Share by Region in 2021
Figure 50. Middle East & Africa Mesalamine (Lialda) Market Size Market Share by Type in 2021
Figure 51. Middle East & Africa Mesalamine (Lialda) Market Size Market Share by Application in 2021
Figure 52. Egypt Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 53. South Africa Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 54. Israel Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 55. Turkey Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 56. GCC Country Mesalamine (Lialda) Market Size Growth 2017-2022 ($ Millions)
Figure 57. Americas Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 58. APAC Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 59. Europe Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 60. Middle East & Africa Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 61. United States Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 62. Canada Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 63. Mexico Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 64. Brazil Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 65. China Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 66. Japan Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 67. Korea Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 68. Southeast Asia Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 69. India Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 70. Australia Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 71. Germany Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 72. France Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 73. UK Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 74. Italy Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 75. Russia Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 76. Spain Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 77. Egypt Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 78. South Africa Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 79. Israel Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 80. Turkey Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Figure 81. GCC Countries Mesalamine (Lialda) Market Size 2023-2028 ($ Millions)
Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029
Published: 11-Jan-2024 Price: US 3350 Onwards Pages: 118
The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029.
Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029.
Report Scope
This report aims to provide a comprehensive presentation of the glo......
Global Non-imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 95
The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
Global Imaging Diagnostic Catheter Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 90
The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......
Global PCR Equipment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 77
The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030.
PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers:
Advancements in Research and Diagnost......
Global Disposable Sterile Syringes and Needles Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 109
The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030.
North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Disposable Sterile Syringes and N......
Global Orthopaedic Power Tools Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 106
The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030.
North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......
Global Cerebrospinal Fluid Management Devices Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 86
The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......
Global CAD & CAM Milling Burs Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 79
The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......
Global Artificial Teeth Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 98
The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030.
North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030.
Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
